2019
DOI: 10.3390/md17080453
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Antimicrobial Peptides from the Microalgae Tetraselmis suecica (Kylin) Butcher and Bactericidal Activity Improvement

Abstract: The outburst of microbial resistance to antibiotics creates the need for new sources of active compounds for the treatment of pathogenic microorganisms. Marine microalgae are of particular interest in this context because they have developed tolerance and defense strategies to resist the exposure to pathogenic bacteria, viruses, and fungi in the aquatic environment. Although antimicrobial activities have been reported for some microalgae, natural algal bioactive peptides have not been described yet. In this wo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
33
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 86 publications
(35 citation statements)
references
References 54 publications
(69 reference statements)
0
33
0
2
Order By: Relevance
“…The purified peptide, FPIGMGHGSRPA, inhibited several pathogenic bacteria, such as B. cereus , B. subtilis , S. aureus , Salmonella sp., Listeria innocua , and Escherichia coli at IC 50 concentrations of 2.0–3.8 μM [ 277 ]. These harmful bacteria were also inhibited by the AQ-1766 peptide extracted from marine microalgae, e.g., Tetraselmis suecica with minimal bactericidal concentrations (MBC) of 40–50 μM [ 278 ]. Similar bioactivities have also been reported for protein hydrolysates and peptides produced from other species such as D. salina [ 260 ] and Chlorella pyrenoidosa [ 279 ].…”
Section: Nutritional Quality and Biological Activities Of Marine-dmentioning
confidence: 99%
“…The purified peptide, FPIGMGHGSRPA, inhibited several pathogenic bacteria, such as B. cereus , B. subtilis , S. aureus , Salmonella sp., Listeria innocua , and Escherichia coli at IC 50 concentrations of 2.0–3.8 μM [ 277 ]. These harmful bacteria were also inhibited by the AQ-1766 peptide extracted from marine microalgae, e.g., Tetraselmis suecica with minimal bactericidal concentrations (MBC) of 40–50 μM [ 278 ]. Similar bioactivities have also been reported for protein hydrolysates and peptides produced from other species such as D. salina [ 260 ] and Chlorella pyrenoidosa [ 279 ].…”
Section: Nutritional Quality and Biological Activities Of Marine-dmentioning
confidence: 99%
“…Apart from these phycobiliproteins, microalgae also produce protein products, like whole-cell protein, protein hydrolysates, protein concentrates, and peptides which have different biological activities ( Soto-Sierra et al, 2018 ). Microalgal peptides isolated from S. maxima , S. obliquus, and T. suecica have been reported to exert anti-inflammatory, antioxidant, and antimicrobial activity, respectively ( Vo et al, 2013 ; Montone et al, 2018 ; Guzmán et al, 2019 ).…”
Section: Potential Microalgal Antioxidants For Use In Cancer Therapiementioning
confidence: 99%
“…Peptides namely AQ-1756, AQ-1757, and AQ-1766 identified from Tetraselmis suecica exhibited an antibacterial activity resulting in decreasing cell viability (human embryonic kidney cells) (HEK293) upto 75% after 24 h of treatment. AQ-1766 was more active against Gram + than Grambacteria, with MBC values between 40 and 50 µM [183].…”
Section: Antimicrobial Activity Of Microalgaementioning
confidence: 99%